LaRocco M T, Burgert S J
Department of Pathology, St. Luke's Episcopal Hospital, Houston, TX 77225-0269, USA.
Clin Microbiol Rev. 1997 Apr;10(2):277-97. doi: 10.1128/CMR.10.2.277.
Over the past quarter century, tremendous technological advances have been made in bone marrow and solid organ transplantation. Despite these advances, an enduring problem for the transplant recipient is infection. As immunosuppressive regimens have become more systematic, it is apparent that different pathogens affect the transplant recipient at different time points in the posttransplantation course, since they are influenced by multiple intrinsic and extrinsic factors. An understanding of this evolving risk for infection is essential to the management of the patient following transplantation and is a key to the early diagnosis and treatment of infection. Likewise, diagnosis of infection is dependent upon the quality of laboratory support, and services provided by the clinical microbiology laboratory play an important role in all phases of clinical transplantation. These include the prescreening of donors and recipients for evidence of active or latent infection, the timely and accurate microbiologic evaluation of the transplant patient with suspected infection, and the surveillance of asymptomatic allograft recipients for infection. Expert services in bacteriology, mycology, parasitology, virology, and serology are needed and communication between the laboratory and the transplantation team is paramount for providing clinically relevant, cost-effective diagnostic testing.
在过去的四分之一世纪里,骨髓和实体器官移植技术取得了巨大进步。尽管有这些进展,但移植受者面临的一个长期问题是感染。随着免疫抑制方案变得更加系统化,很明显不同的病原体在移植后的不同时间点影响移植受者,因为它们受到多种内在和外在因素的影响。了解这种不断演变的感染风险对于移植后患者的管理至关重要,也是感染早期诊断和治疗的关键。同样,感染的诊断取决于实验室支持的质量,临床微生物实验室提供的服务在临床移植的各个阶段都发挥着重要作用。这些包括对供体和受体进行预筛查,以寻找活动性或潜伏性感染的证据,对疑似感染的移植患者进行及时、准确的微生物学评估,以及对无症状同种异体移植受者进行感染监测。需要细菌学、真菌学、寄生虫学、病毒学和血清学方面的专业服务,实验室与移植团队之间的沟通对于提供临床相关、具有成本效益的诊断检测至关重要。